Deep Vein Thrombosis — a CLOT in a deep vein · plus Raynaud's & Buerger's
A clot in a deep vein is not dangerous where it sits — it is dangerous where it GOES. Blood from a leg vein travels to the right heart and straight into the lungs. That is why the calf you find swollen today is a pulmonary embolism tomorrow, and why you never massage or vigorously palpate a calf you suspect of clotting.
📄 Simple Nursing original — opens in Drive →
Three conditions make blood clot where it shouldn't. Every risk factor you'll ever be asked about slots into one of them.
| Triad leg | Who's at risk |
|---|---|
| 🧍 STASIS | Post-op & immobile clients · bed rest · casts and splints · paralysis/stroke · long car rides and flights · prolonged sitting · heart failure · obesity · pregnancy (the uterus compresses pelvic veins) |
| 🩹 INJURY | Orthopedic surgery — especially hip and knee replacement · major trauma and fractures · central lines and IV catheters · smoking |
| 🧬 HYPERCOAG | Cancer (and chemotherapy) · dehydration · pregnancy and postpartum · estrogen therapy / oral contraceptives, especially in a smoker over 35 · inherited thrombophilias · sepsis · previous DVT |
The highest-yield combination on the exam: a post-operative orthopedic client who has been in bed and is not yet ambulating. That is all three legs at once.
Four letters for the leg. One line for the lungs. And one thing your hands must never do.
Also assess: pain on dorsiflexion, a palpable cord, and skin that looks tight and shiny. Do not chart a DVT “ruled out” on findings alone — many DVTs are silent until the PE.
Order matters on the exam: when the client is in front of you, do the things that fix oxygenation first (position + O₂), then get help, then gather data. Don't leave the room to page someone.
Anticoagulants don't dissolve the clot — they stop it from growing while the body breaks it down. Prevention is where nursing wins.
| Drug | Route & speed | Monitoring | Nursing key points |
|---|---|---|---|
| Heparin unfractionated |
IV drip or SC. Immediate onset — this is the one you start in an emergency. | aPTT (some facilities use anti-Xa). Therapeutic ≈ 1.5–2.5× the control value. Also follow PLATELETS. | Antidote protamine sulfate. Watch for HIT — heparin-induced thrombocytopenia: platelets fall (classically >50% drop) and the client paradoxically clots. Stop the heparin and notify. Never rub SC injection sites. |
| LMWH enoxaparin, dalteparin |
SC, weight-based, more predictable than heparin. | No routine aPTT. Anti-Xa level only in select cases (renal impairment, pregnancy, extremes of weight). Follow platelets and renal function. | Give in the abdomen, about 2 inches from the umbilicus. Do not expel the air bubble, do not aspirate, do not massage the site. Protamine reverses it only partially. |
| Warfarin | PO. Slow — takes several days for full effect, so it is overlapped (“bridged”) with heparin at the start. | PT / INR. Normal INR ≈ 0.8–1.2; therapeutic for VTE/AF is 2.0–3.0. Above range = bleeding risk; below = clot risk. | Antidote vitamin K (phytonadione); major bleeding also gets FFP or prothrombin complex concentrate. Teach consistent vitamin-K intake (green leafy vegetables) — consistency, not avoidance. Many drug/herbal interactions. Contraindicated in pregnancy. |
| DOACs apixaban, rivaroxaban, edoxaban (factor Xa) · dabigatran (direct thrombin) |
PO, fixed dosing, rapid onset. | No routine coagulation monitoring — no INR. Renal function is checked because clearance depends on it. | Reversal: idarucizumab for dabigatran; andexanet alfa for the factor Xa inhibitors. Keep dabigatran in its original bottle and do not crush or open the capsules. Missing doses matters — the protection wears off fast. |
| Thrombolytics alteplase |
IV, reserved for massive PE or a limb-threatening clot. | Continuous monitoring for bleeding of any kind. | Actually dissolves existing clot — and carries the highest bleeding risk of anything on this page. Contraindicated with active bleeding, recent surgery or trauma, and a history of hemorrhagic stroke. |
Two nuances the exam cares about:
What it is: a small mesh basket placed in the inferior vena cava to catch clots traveling from the legs before they reach the lungs.
Who gets one: clients who cannot take anticoagulants (active bleeding, recent neurosurgery) or who keep throwing clots despite therapeutic anticoagulation.
What it does NOT do: it does not dissolve clots and it does not prevent new ones from forming — it is a net, not a treatment.
| 🤍 RAYNAUD'S · “R = Ring finger” | 🖤 BUERGER'S · “B = Black fingers & toes” |
|---|---|
| Spasm of small arteries in the fingers (and toes), triggered by COLD and STRESS. | Buerger's disease (thromboangiitis obliterans) — inflammation and clotting of small and medium arteries and veins in the hands and feet. |
| Classic color sequence: WHITE (spasm, no blood) → BLUE (deoxygenated) → RED (blood rushes back). Numbness, tingling, throbbing. | Tissue actually dies: intense pain, claudication of the arch of the foot, cold sensitivity, ulcers, and black gangrenous fingers & toes. |
| Care: keep warm — gloves, warm environment, warm water; avoid cold, caffeine, nicotine; manage stress. Calcium channel blockers are commonly used vasodilators. | Care: absolute, complete tobacco cessation — this is the treatment. Nothing else works if the client keeps smoking. Protect and inspect the extremities; amputation if gangrene. |
| Episodic and reversible. | Progressive and destructive. Strongly associated with tobacco use in younger adults. |
Saved study graphics from your own collection. Each one is someone else’s work — check anything clinical against your course materials before you rely on it.